Routine Immunizations Linked to Decline in Rotavirus Hospitalizations, Health Care Costs
The introduction of routine rotavirus vaccinations resulted in substantial reductions in diarrhea-related hospitalization in children, as well as associated health care costs.
The introduction of routine rotavirus vaccinations resulted in substantial reductions in diarrhea-related hospitalization in children, as well as associated health care costs, according to a study published in the Journal of the Pediatric Infectious Diseases Society.
The analysis builds on previous research that demonstrated a
In the study, the researchers analyzed data focusing on hospitalization for acute gastroenteritis among children younger than age 5, comparing the periods before and after vaccination licensure in 2006. After the implementation of routine rotavirus immunization, diarrhea hospitalizations decreased by between 31% to 55% from 2008 to 2013.
After routine rotavirus vaccinations were introduced, direct medical costs savings for avoided diarrhea hospitalization amounted to $1.2 billion nationwide during the 2008-2013 period. However, the researchers noted that this amount likely underestimates the overall economic effect because other costs, such as averted clinician’s office or emergency room visits, were not included.
In 2015, the researchers estimated that 73% of US children aged 19-35 months old received the rotavirus vaccine, which is lower than rates for other routine childhood vaccines such as diphtheria, tetanus, and acellular pertussis (DTaP) vaccine. The researchers concluded that efforts to further increase rotavirus vaccine uptake could better protect children against the disease and result in substantial health care savings.
Reference
Leshem E, Tate JE, Steiner CA, et al. National estimates of reductions in acute gastroenteritis-related hospitalizations and associated costs in US children after implementation of rotavirus vaccines. J Pediatr Infect Dis Soc. 2017.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- IMS 2025: Improving Outcomes with Bispecifics in Multiple Myeloma
September 19th 2025
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025